Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,697 across all filing types
Latest filing 2019-06-28 Regulatory Filings
Country TW Taiwan
Listing TW 4119

About SCI

www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
108年06月法人說明會簡報 — 411920190628M001.pdf
Regulatory Filings
2019-06-28 Chinese
108年06月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting, including date, time, location, and links to presentation materials. The content focuses on a '法人說明會' which translates to 'investor presentation' or 'analyst meeting'. There is no financial data or report attached, just references to presentation files and meeting details. This matches the definition of an Investor Presentation (IP). The document length is short and it is not an announcement of a report publication but the actual presentation information. Therefore, the correct classification is Investor Presentation (IP).
2019-06-28 Chinese
公告本公司於6月28日受統一證券邀請說明營運概況
Investor Presentation Classification · 95% confidence The document is a short announcement about a scheduled investor presentation (法人說明會) by the company 4119 旭富 on June 28, 2019, including details such as date, time, location, and topic (operational overview). It does not contain actual financial data or detailed report content but rather informs about the event where such information will be presented. The document length is only 618 characters, indicating it is a brief notice rather than a full report. Therefore, it fits the category of an Investor Presentation announcement (IP).
2019-06-27 Chinese
澄清6月27日工商時報B5版報導
Regulatory Filings Classification · 95% confidence The document is a short announcement (731 characters) clarifying a media report about the company's financial forecast. It states that the company has not publicly disclosed financial forecasts and refers readers to the official public information site for detailed financial data. There are no actual financial statements or detailed financial analysis included in the text. The document serves as a clarification or regulatory announcement rather than a full financial report or earnings release. According to the rules, such short clarifications or announcements that do not contain substantive financial data should be classified as Regulatory Filings (RNS).
2019-06-27 Chinese
公告本公司功能性委員會成員選任。
Board/Management Information Classification · 95% confidence The document is a short announcement (968 characters) about the appointment and reappointment of members to the company's functional committees, specifically the Audit Committee and the Remuneration Committee. It details names, positions, and reasons for changes (term expiration and re-election). There is no financial data, no mention of financial results, no report attached or referenced, and no regulatory certification or voting results. The content clearly relates to changes in company governance structure, specifically committee membership, which falls under Board/Management Information. The document is not a full report but an announcement of management/board changes.
2019-06-21 Chinese
公告本公司108年股東常會解除董事競業禁止之事宜。
Board/Management Information Classification · 95% confidence The document is a regulatory announcement from a listed company (4119 旭富) regarding a shareholder meeting decision to lift the non-competition restriction on a director. It includes details about the resolution date, director's name and position, the scope of permitted competitive activities, and voting results. The content is a formal disclosure of a board/management-related decision rather than a financial report or earnings release. It does not contain financial statements or detailed financial data. The document length is short (868 characters), and it is a specific announcement about board-related matters. Therefore, it fits best under Board/Management Information (MANG).
2019-06-21 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.